The use of angiotensin II antagonists is not recommended during the first trimester of pregnancy. The use of angiotensin II antagonists is contra-indicated during the 2nd and 3rd trimester of pregnancy.
It is not known whether Olmesartan is excreted in human milk. Because no information is available regarding the use of Olmesartan Medoxomil during breast-feeding, Olmesartan Medoxomil is not recommended.